Guangzhou, Guangdong, China In 1994 was created KingMed Diagnostics, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Guangzhou. The venture was found in Asia in China.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AnchorDx. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular fund investment industries, there are Emergency Medicine, Pharmaceutical.
The typical case for the fund is to invest in rounds with 4 participants. Despite the KingMed Diagnostics, startups are often financed by Northern Light Venture Capital, Marathon Venture Partners. The meaningful sponsors for the fund in investment in the same round are WuXi AppTec, Sijia Jianxin Fund, Marathon Venture Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 8-Bit Capital | California, San Francisco, United States |
| Ansera Capital Partners | British Columbia, Canada, Vancouver |
| Bincot | - |
| Commodore Capital | New York, New York, United States |
| Crabtree Ventures | Chicago, Illinois, United States |
| G and M Capone Trust | Adelaide, Australia, South Australia |
| Kissei Pharmaceutical | Japan, Matsumoto, Nagano Prefecture |
| Louisiana Board of Regents | Baton Rouge, Louisiana, United States |
| MEST Express accelerator | Accra, Ghana, Greater Accra |
| Ontario Pension Board | Canada, Ontario, Toronto |
| PEAK6 Investments, L.P. | Chicago, Illinois, United States |
| Seed + Speed Ventures | Berlin, Berlin, Germany |
| Shuijingshi Equity | - |
| Sinclair Broadcast Group | Hunt Valley, Maryland, United States |
| Tokyo Commodity Exchange | - |
| Touchstone Innovations | England, London, United Kingdom |
| Trends Media | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
GeneMind Biosciences | $61M | 02 Aug 2023 | Jiangxi, Guangdong, China | ||
Biotree | 03 Jan 2023 | Shanghai, China | |||
Yikon Genomics | $31M | 04 Nov 2019 | Minhang District, China | ||
AnchorDx | $28M | 07 Nov 2017 | Yuexiu District, Guangdong Province |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
GeneMind Biosciences | $61M | 02 Aug 2023 | Jiangxi, Guangdong, China | ||
Biotree | 03 Jan 2023 | Shanghai, China | |||
Yikon Genomics | $31M | 04 Nov 2019 | Minhang District, China | ||
AnchorDx | $28M | 07 Nov 2017 | Yuexiu District, Guangdong Province |
